Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072565 · ClinicalTrials.gov registry record · NA
Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT01072565 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 91 participants.
The verdict
NCT01072565, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.
Interventions
- OTHER SMBG to guide clinical decisions
- OTHER SMBG and CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072565
The ClinicalTrials.gov registry entry for NCT01072565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMBG to guide clinical decisions is the first listed.
NCT01072565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072565 about?
NCT01072565 is a clinical study titled "Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring". The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.
What is the current status of trial NCT01072565?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2010-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01072565?
The interventions under investigation include: SMBG to guide clinical decisions (OTHER), SMBG and CGM (OTHER).
Who is sponsoring clinical trial NCT01072565?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.